Inflammation is your immune system’s built-in alarm-and-repair response, a cascade of molecular and cellular events triggered whenever tissue is damaged or invaded. It evolved as a protective mechanism, though that protection comes with a cost to normal tissue function, a trade-off shaped over millions of years of evolution.
The Five Classic Signs and What Causes Them
Nearly two thousand years ago, the Roman writer Celsus described four cardinal signs of inflammation: redness, swelling, heat, and pain. A fifth sign, loss of function, was added centuries later.
These signs are not random symptoms. Each one traces back to specific changes in your blood vessels and surrounding tissue. When cells are injured or a pathogen breaches the skin, immune sensors called pattern recognition receptors detect the threat. These receptors pick up on molecular signatures from invading microbes as well as distress signals released by damaged cells, and they kick-start the inflammatory cascade by triggering the production of signaling molecules called cytokines.
Within minutes, small blood vessels near the injury site widen, increasing blood flow to the area. That extra blood is why inflamed tissue turns red and feels warm. The vessel walls also become more permeable, allowing fluid and immune cells to leak into the surrounding tissue. The fluid accumulation causes swelling, and the combined pressure and chemical irritation stimulate nerve endings, producing pain. Loss of function follows naturally: a swollen, painful joint or organ simply cannot work at full capacity.
What Happens at the Cellular Level During Acute Inflammation
Once the alarm sounds, the first wave of immune cells to arrive are neutrophils, a type of white blood cell that acts like a rapid-response unit. Neutrophils reach the site within hours, squeezing through the now-leaky vessel walls and heading toward the source of trouble. They fight invaders in several ways: engulfing and digesting microbes, releasing bactericidal proteins, generating bursts of toxic oxygen-containing molecules, and casting out web-like structures called neutrophil extracellular traps that physically snare pathogens.
Behind the neutrophils come other immune cells, including monocytes that mature into macrophages once they enter the tissue. Macrophages are versatile: they can destroy pathogens, clean up dead cells and debris, and later switch to a repair-oriented mode that promotes tissue healing.
All of this activity is coordinated by chemical mediators. Two major groups stand out: prostaglandins and cytokines. Prostaglandins are lipid-based molecules that help regulate blood flow, sensitize pain receptors, and modulate fever. Cytokines are small proteins that serve as communication signals between immune cells, amplifying or dampening the response as needed. Other mediators, including vasoactive amines like histamine and acute-phase proteins produced by the liver, add further layers of control.
How Inflammation Shuts Itself Off
A widespread misconception is that inflammation simply fades once the threat is gone, like a fire burning out. In reality, resolution is an actively orchestrated process with its own dedicated molecular machinery. Your body produces a family of molecules called specialized pro-resolving mediators, many of them derived from omega-3 fatty acids, that actively limit further inflammation and promote tissue repair without compromising your ability to fight infection.
These resolution signals tell neutrophils to stop arriving, encourage macrophages to switch from attack mode to cleanup mode, and stimulate the rebuilding of damaged tissue. The process has been compared to an active “off switch” rather than the passive absence of an “on switch.” When this resolution phase works properly, the tissue returns to its normal state within days to weeks, depending on the severity of the initial insult.
The critical requirement for resolution to succeed is straightforward: the original cause of the inflammation must be eliminated. If the injurious agent persists, whether it is a lingering infection, a foreign body, or an ongoing chemical exposure, the resolution program cannot complete, and the inflammatory response transitions into a chronic state.
When Acute Becomes Chronic
Chronic inflammation is fundamentally different from its acute counterpart in character, not just duration. Where acute inflammation is loud, localized, and fast, chronic inflammation is typically low-grade, widespread, and persistent. Instead of the dramatic redness and swelling of a fresh wound, chronic inflammation simmers quietly in the background, often producing no obvious symptoms for years.
The cellular cast changes too. Rather than neutrophil-dominated early responses, chronic inflammation features macrophages, lymphocytes, and other long-lived immune cells that settle into tissues and continuously release inflammatory mediators. Macrophages in chronically inflamed tissue can shift between pro-inflammatory and repair-oriented states depending on local signals, and when the balance tips toward persistent activation, the result is ongoing tissue damage and fibrosis.
This shift from acute to chronic often happens because the resolution phase described above fails. The failure can stem from a stimulus that cannot be cleared, such as an autoimmune reaction where the immune system attacks the body’s own tissues, or from metabolic conditions that generate a steady stream of inflammatory signals even without an infection.
What Fuels Chronic Inflammation
Research over the past two decades has identified a range of social, environmental, and lifestyle factors that promote systemic chronic inflammation. These include physical inactivity, poor diet, environmental toxicants, psychological stress, and chronic infections, and the diseases they collectively contribute to represent some of the leading causes of disability and death worldwide.
Excess body fat is one of the best-studied drivers. Fat tissue is not an inert energy depot; it is metabolically active and, when enlarged, attracts immune cells that churn out inflammatory cytokines. This metabolically driven, low-grade inflammation of adipose tissue has been given its own name: metaflammation. It links obesity to insulin resistance, type 2 diabetes, cardiovascular disease, and certain cancers through pathways that are increasingly well mapped.
The gut plays a surprisingly central role. Your intestinal lining acts as a selective barrier, letting nutrients through while keeping bacteria and their byproducts contained. When this barrier is disrupted, a condition sometimes called “leaky gut,” bacterial components like lipopolysaccharide can leak into the bloodstream and provoke a low-level immune response throughout the body. Disruption of this barrier has been connected to the development or worsening of obesity, fatty liver disease, cardiovascular disease, type 1 diabetes, and neurodegenerative conditions. In metabolic disorders like obesity and type 2 diabetes, beneficial gut microbes that produce protective short-chain fatty acids tend to decline, while pro-inflammatory microbes increase, placing additional stress on the intestinal lining.
The Disease Connections
Chronic low-grade inflammation is now recognized as a shared feature of metabolic and neurodegenerative diseases. Type 2 diabetes, for instance, has emerged as a significant risk factor for age-related brain diseases, with evidence pointing to a bidirectional relationship: metabolic dysfunction shapes brain inflammation, and neuroinflammation in turn worsens metabolic control. The link between insulin resistance and impaired cognitive performance appears to run through inflammatory pathways that damage both peripheral tissues and the central nervous system.
Heart disease, certain cancers, autoimmune conditions like rheumatoid arthritis, and inflammatory bowel disease all share chronic inflammation as a contributing factor, though the specific pathways differ. The common thread is that the immune system’s protective machinery, when chronically activated, gradually damages the very tissues it was designed to defend. This is, at its core, the same evolutionary trade-off that makes acute inflammation both necessary and costly, except stretched out over years or decades.
How Doctors Measure Inflammation
Because chronic inflammation often produces no visible symptoms, blood tests for inflammatory markers are an important diagnostic tool. The two most commonly ordered are C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR). CRP is a protein produced by the liver in response to inflammatory signals, and its blood level rises and falls relatively quickly as inflammation waxes and wanes. ESR measures how fast red blood cells settle in a tube over an hour, an indirect gauge of inflammation. Of the two, CRP is the better indicator: it is more sensitive, responds more quickly to changes, and produces fewer false results.
Doctors sometimes order a high-sensitivity version of the CRP test (hs-CRP) specifically to detect the low-grade inflammation associated with cardiovascular risk, since standard CRP tests are designed to pick up the much higher levels seen in acute infections or flares of autoimmune disease. Other markers, including interleukin-6, tumor necrosis factor-alpha, and fibrinogen, are used in research and occasionally in clinical settings, but CRP remains the workhorse.
Medications That Target Inflammation
Nonsteroidal anti-inflammatory drugs, the familiar category that includes ibuprofen and aspirin, work by blocking the enzymes that produce prostaglandins. By reducing prostaglandin levels, these drugs dampen pain, swelling, and fever. They are effective for acute flares but are not ideal for long-term use because of side effects on the stomach lining, kidneys, and cardiovascular system.
Corticosteroids like prednisone take a broader approach. They suppress the release of the raw material, arachidonic acid, that the body uses to make both prostaglandins and another family of inflammatory molecules called leukotrienes. This wider suppression makes corticosteroids powerful anti-inflammatory agents for conditions like asthma and rheumatoid arthritis, but it also means they blunt immune defenses more broadly, which is why long-term steroid use carries risks of infection and bone loss.
For chronic inflammatory diseases like rheumatoid arthritis or inflammatory bowel disease, newer biologic drugs target specific cytokines or immune-cell pathways. These medications are more precise than corticosteroids, but they are expensive, require injection or infusion, and still carry infection risks because they deliberately tamp down parts of the immune system.
Exercise and Diet as Anti-Inflammatory Tools
Regular aerobic exercise is one of the most consistently supported lifestyle interventions for reducing chronic inflammation. A recent meta-analysis of studies in older adults found that aerobic training significantly lowered blood levels of CRP, interleukin-6, and tumor necrosis factor-alpha while raising levels of interleukin-10, an anti-inflammatory cytokine. The benefits were particularly pronounced in populations at risk for chronic inflammatory diseases.
Dietary patterns also matter. Adherence to a Mediterranean-style diet, rich in fruits, vegetables, whole grains, olive oil, and fish, has been associated with reduced inflammation and lower rates of chronic disease in observational and interventional studies. The anti-inflammatory effects likely stem from a combination of factors: high intake of omega-3 fatty acids (precursors of those pro-resolving mediators), polyphenols with antioxidant activity, and fiber that feeds beneficial gut bacteria. No single “anti-inflammatory superfood” drives the effect; the pattern as a whole is what seems to matter.
Sleep and stress management round out the picture. Chronic sleep deprivation raises inflammatory markers, as does sustained psychological stress, partly through elevated cortisol that, paradoxically, promotes inflammation when it stays high rather than spiking briefly. The common advice to eat well, exercise, sleep enough, and manage stress is not just wellness platitudes; each of these behaviors directly modulates the molecular pathways of inflammation.
Why Inflammation Gets Worse With Age
As you get older, your body accumulates senescent cells, cells that have stopped dividing but have not died. These cells linger in tissues and continuously secrete a cocktail of pro-inflammatory molecules known as the senescence-associated secretory phenotype. Senescent cells tend to pile up at the sites of age-related diseases, including degenerative disorders and cancers, and the chronic inflammation they produce may be a main driver of those conditions. This age-related creep in background inflammation has been dubbed “inflammaging” by researchers, and it helps explain why the risk of heart disease, diabetes, cancer, and dementia all rise in parallel with advancing age.
The concept also highlights why lifestyle interventions become more, not less, important as people age. If the baseline inflammatory load is already climbing due to cellular aging, adding further inflammatory fuel through inactivity, poor diet, or excess body weight compounds the problem.
Trained Immunity and Inflammatory Memory
One of the more surprising discoveries of the past decade is that your innate immune system has a form of memory. The textbook distinction used to be clean: the adaptive immune system (the one that makes antibodies) remembers past infections, while the innate immune system (the one that triggers inflammation) responds the same way every time. That turns out to be incomplete.
Innate immune cells, particularly monocytes and macrophages, can be reprogrammed by a first encounter with a pathogen so that they respond more vigorously to a second, unrelated challenge. This phenomenon, called trained immunity, is driven by lasting changes in how genes are read, specifically by chemical modifications to the DNA-packaging proteins that control gene expression, without any change to the DNA sequence itself. The practical result is that your inflammatory response can be “set” to a higher or lower baseline depending on past exposures.
Trained immunity has a bright side: it can provide broad protection against infections that the adaptive immune system has never seen. But there is a dark side too. If immune cells are trained into a persistently heightened state, they may contribute to chronic inflammatory conditions. This area of research is still young, but it is reshaping how scientists think about diseases where inflammation seems disproportionate to any identifiable trigger.
The Vagus Nerve as an Inflammation Brake
Your nervous system and immune system are not as separate as they were once thought to be. The vagus nerve, the longest cranial nerve in the body, runs from the brainstem to the abdomen and acts as a direct communication line between the brain and the organs. Research has revealed that signals traveling down the vagus nerve can actively suppress inflammation through what is called the cholinergic anti-inflammatory pathway. When the vagus nerve fires, it releases acetylcholine, a neurotransmitter that binds to specific receptors on macrophages and dials down the production of pro-inflammatory cytokines like tumor necrosis factor-alpha and interleukin-1-beta while boosting the anti-inflammatory cytokine interleukin-10.
This discovery has opened the door to a novel therapeutic approach: electrical stimulation of the vagus nerve to treat inflammatory diseases. In animal models of acute respiratory distress syndrome, vagus nerve stimulation reduced lung injury by promoting the cholinergic anti-inflammatory pathway. Early human trials in rheumatoid arthritis and inflammatory bowel disease have also shown promise, though the technology is still being refined. The broader implication is that inflammation is not governed solely by immune cells talking to each other. The brain is listening, and it has the wiring to intervene.
When Acute Inflammation Becomes Dangerous on Its Own
Although acute inflammation is usually self-limiting, it can become life-threatening when the response spirals out of control. In severe infections, the interaction between cytokines, blood-vessel cells, and immune cells can trigger what is sometimes called a cytokine storm, a runaway amplification loop that damages organs far from the original site of infection. During sepsis, the cells lining blood vessels undergo changes that are initially adaptive but eventually harmful, leading to widespread leakage, clotting abnormalities, and organ failure. COVID-19 brought this concept into public awareness, as some of the most severe cases involved an overblown inflammatory response in the lungs and other organs rather than direct viral damage alone.
The lesson is that inflammation exists on a spectrum even in its acute form. A small cut heals neatly. A major trauma, a widespread infection, or a genetically susceptible host can push the same protective machinery past its tipping point, turning defense into destruction. Understanding where you sit on that spectrum, and what shifts it, is really the central question behind all inflammation research.